Overview
Lung cancer
We treat lung cancers and other less common cancers found near the lungs. This includes mesothelioma and cancer of the thymus, a gland between the lungs.
This group of cancers are sometimes described by doctors as thoracic malignancies.
We aim to assess and diagnose your cancer quickly. We use a range of tests, scans and investigations to do this. These include:
- CT scan, MRI scan or PET-nuclear medicine scan
- bronchoscopy or endobronchial ultrasound (EBUS). This involves putting a thin tube with a camera through your mouth or nose and into your airways. The aim is to photograph, examine and take a small sample of tissue (biopsy) from your lungs or airways. EBUS also uses ultrasound to take a sample of your lymph nodes
- surgery
- interventional radiology
- expert pathology. This includes testing samples of your tumour to help identify the best treatments
- genomics (studying your genes to help diagnosis)
Your treatment depends on the type and stage of your cancer. It may involve:
- surgery
- radiotherapy, including stereotactic radiotherapy, given from different angles at the same time
- chemotherapy
- other systemic therapies such as immunotherapy
You can find out more about lung cancer treatments on the NHS website.
We're committed to providing you with personalised cancer care. You can read more about what this means on our cancer care and support page.
You'll have access to:
- advice from a dietitian
- benefits and welfare advice through Dimbleby Cancer Care
- patient support groups
- physiotherapy
- psychological support
- occupational therapy
- speech and language therapy
Wards
You may need to stay in hospital on one of our wards during your treatment:
Our consultants
Michael Skwarski
Research and clinical trials
Research is vital to improving the care that you receive when you're unwell. You can help improve healthcare by taking part in research studies at our Trust. During your appointment, ask your healthcare professional about research. They'll be happy to tell you about research studies you could be eligible to join.
You can also email [email protected] for more information.
We have a dedicated clinical trials team. They focus on national and international trials and the development of new therapies.
